nitrites has been researched along with Liver Cirrhosis, Biliary in 7 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the potential antioxidant effects of N-acetylcysteine in hepatopulmonary syndrome, a complication of cirrhosis, using an experimental model of common bile duct ligation in rats." | 7.74 | N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. ( Dias, AS; Garcia, E; Marroni, CA; Marroni, NP; Meurer, L; Picada, JN; Tieppo, J; Vercelino, R, 2008) |
| "The therapeutic efficacy of bezafibrate, a hypolipidemic drug, has been shown in patients with primary biliary cirrhosis (PBC) in some pilot studies; however, little is known regarding the mechanism of action of bezafibrate in PBC." | 7.73 | Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis. ( Abe, M; Akbar, SM; Furukawa, S; Horiike, N; Nakanishi, S; Onji, M, 2005) |
| "The aim of this study was to evaluate the potential antioxidant effects of N-acetylcysteine in hepatopulmonary syndrome, a complication of cirrhosis, using an experimental model of common bile duct ligation in rats." | 3.74 | N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. ( Dias, AS; Garcia, E; Marroni, CA; Marroni, NP; Meurer, L; Picada, JN; Tieppo, J; Vercelino, R, 2008) |
| "The therapeutic efficacy of bezafibrate, a hypolipidemic drug, has been shown in patients with primary biliary cirrhosis (PBC) in some pilot studies; however, little is known regarding the mechanism of action of bezafibrate in PBC." | 3.73 | Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis. ( Abe, M; Akbar, SM; Furukawa, S; Horiike, N; Nakanishi, S; Onji, M, 2005) |
| "Biliary cirrhosis was accompanied with a decrease in baseline perfusion pressure in mesenteric vascular bed (P < 0." | 1.35 | Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis. ( Dehpour, AR; Ebrahimkhani, MR; Kiani, S; Merat, S; Moezi, L, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbar, SM | 1 |
| Furukawa, S | 1 |
| Nakanishi, S | 1 |
| Abe, M | 1 |
| Horiike, N | 1 |
| Onji, M | 1 |
| Mani, AR | 1 |
| Ippolito, S | 1 |
| Ollosson, R | 1 |
| Moore, KP | 1 |
| Trebicka, J | 1 |
| Leifeld, L | 1 |
| Hennenberg, M | 1 |
| Biecker, E | 1 |
| Eckhardt, A | 1 |
| Fischer, N | 1 |
| Pröbsting, AS | 1 |
| Clemens, C | 1 |
| Lammert, F | 1 |
| Sauerbruch, T | 1 |
| Heller, J | 1 |
| Vercelino, R | 1 |
| Tieppo, J | 1 |
| Dias, AS | 1 |
| Marroni, CA | 1 |
| Garcia, E | 1 |
| Meurer, L | 1 |
| Picada, JN | 1 |
| Marroni, NP | 1 |
| Ebrahimkhani, MR | 1 |
| Moezi, L | 1 |
| Kiani, S | 1 |
| Merat, S | 1 |
| Dehpour, AR | 1 |
| Marley, R | 1 |
| Holt, S | 1 |
| Fernando, B | 1 |
| Harry, D | 1 |
| Anand, R | 1 |
| Goodier, D | 1 |
| Davies, S | 1 |
| Moore, K | 1 |
| Hokari, A | 1 |
| Zeniya, M | 1 |
| Esumi, H | 1 |
| Kawabe, T | 1 |
| Gershwin, ME | 1 |
| Toda, G | 1 |
7 other studies available for nitrites and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis.
Topics: Adult; Bezafibrate; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Liver Function T | 2005 |
Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis.
Topics: Acetylcysteine; Animals; Enzyme Inhibitors; Heart Rate; Immunohistochemistry; Liver Cirrhosis, Bilia | 2006 |
Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
Topics: Administration, Oral; Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Hemodynamics; Kidne | 2008 |
N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome.
Topics: Acetylcysteine; Animals; Antioxidants; Comet Assay; Common Bile Duct; DNA Damage; Hepatopulmonary Sy | 2008 |
Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis.
Topics: Animals; Disease Models, Animal; Ligation; Liver Cirrhosis, Biliary; Male; Mesentery; Naltrexone; Na | 2008 |
Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis.
Topics: Animals; Blood Circulation; Cardiovascular Diseases; Glutathione; Hemodynamics; Lipid Peroxides; Liv | 1999 |
Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury.
Topics: Adult; Female; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Interferon-gamma; Liver; Liv | 2002 |